- Home
- RVMD vs HMC Comparison
RVMD vs HMC Comparison
Compare RVMD & HMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | HMC |
|---|---|---|
| Founded | 2014 | 1946 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3B | 44.2B |
| IPO Year | 2020 | 2002 |
Fundamental Metrics
Financial Performance| Metric | RVMD | HMC |
|---|---|---|
| Price | $183.99 | $36.34 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 3 |
| Target Price | ★ $258.84 | $34.09 |
| AVG Volume (30 Days) | ★ 1.9M | 765.9K |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 1.42% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.46 |
| Revenue Next Year | $526.64 | $2.26 |
| P/E Ratio | ★ N/A | $40.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $58.91 | $23.25 |
| 52 Week High | $224.31 | $35.42 |
Technical Indicators
Market Signals| Indicator | RVMD | HMC |
|---|---|---|
| Relative Strength Index (RSI) | 56.58 | 67.46 |
| Support Level | $198.91 | $31.12 |
| Resistance Level | $207.50 | N/A |
| Average True Range (ATR) | 8.24 | 0.46 |
| MACD | 1.42 | 0.02 |
| Stochastic Oscillator | 86.26 | 93.99 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About HMC Honda Motor Company Ltd.
Incorporated in 1948, Honda Motor was originally a motorcycle manufacturer. Today, the firm makes automobiles, motorcycles, and power products such as boat engines, generators, and lawnmowers. Including joint ventures, Honda sold 3.4 million light vehicles and 22.1 million motorcycles in fiscal 2026, and consolidated sales were JPY 21.8 trillion. Automobiles constitute 64% of revenue and motorcycles 18%, with the rest split between power products and financial services. Honda also makes robots and private jets.